Norepinephrine Bitartrate 4 mg per 250 mL injection, solution

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Baxter Healthcare Corporation names for other drugs.

Recalls

• Jan 23, 2024 · Class II · Baxter Healthcare Corporation
  Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.
  Lots: Lot 23I21G64; Exp. 07/31/2024

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Norepinephrine: every company that makes it

Form

injection, solution, intravenous

Strength

4 mg per 250 mL

Approval

NDA NDA214313

On the market since

Nov 21, 2023

Package NDCs

0338-0040-20

Official label

DailyMed (National Library of Medicine), updated Feb 6, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?